Kohl’s expresses interest in the acquisition of At Home décor chain
Category: #retail  By Paroma Bhattacharya  Date: 2019-05-18
  • share
  • Twitter
  • Facebook
  • LinkedIn

Kohl’s expresses interest in the acquisition of At Home décor chain

At Home has been exploring a sale, for the last 3 months and has already advanced in a deal negotiation with private equity firms, including Hellman and Friedman.

The largest U.S. department store chain operator Kohl’s has recently approached At Home, the home décor superstore chain and expressed interest in acquiring the U.S. based home décor retail chain, reports source.

A deal is expected to expand Kohl’s customer base, that focuses on men, women and children clothing and will boost its presence in the category of home goods, which has traditionally accounted for a small part of its business.

For the record, At Home, specialty retailer’s stores carry over 50,000 unique items across varied product categories including home textiles, furniture, housewares, seasonal décor, patio, rugs and wall décor. At Home stores have a wide range of items, however, the company allocates a large portion of its space to seasonal merchandise. The company went public in 2016 and as of 2019, it owns 185 stores in 37 states in the U.S. and plans to expand to 600 such stores.

Kohl’s has also been looking for new ways to expand its business. For instance, Kohl’s recently announced that it will be accepting return of items that the company has sold on amazon. The service will be available at all its stores, at more than 1,150 locations across U.S.

Recently, it has been reported that there was nearly 2% drop in Kohl’s stock while shares of At Home surged up to more than 7%. At Home Group had a market value of $1.3 billion, as of recent end of trading.

Reportedly, Kohl’s recently initiated conversations with At Home to advance a deal.  At Home has been exploring a sale, for the last 3 months and has already advanced in a deal negotiation with private equity firms, including Hellman and Friedman.

It is uncertain whether an offer from Kohl’s after the preliminary discussion will materialize into a deal with At Home. At Home might revert to sell itself to a buyout company is equally uncertain. According to sources, Hellman and Friedman declined to comment on the matter, while At Home and Kohl’s did not respond to requests for comment.

Source credits:

https://www.cnbc.com/2019/05/15/kohls-explores-acquisition-of-at-home-group.html

https://www.cnbc.com/2019/04/23/kohls-will-offer-amazon-returns-in-all-of-its-stores.html



About Author

Paroma Bhattacharya

Email: [email protected]   

Paroma Bhattacharya

Paroma currently works as a content developer for Algosonline, MSF and a series of alike platforms. Fortified with a post-graduation degree in Journalism and Mass Communication, she delved head long into a writing career, creating resourceful and information enriched ...

Read More

More News By Paroma Bhattacharya

Mirati Therapeutics reveals Phase ½ results of KRAS inhibitor therapy
Mirati Therapeutics reveals Phase ½ results of KRAS inhibitor therapy
By Paroma Bhattacharya

Mirati Therapeutics, an oncology company that engages in the development of targeted therapies, recently released its clinical trial results for MRTX849. Reportedly, MRTX849 is a KRAS G12C inhibitor and the data from P...

Best Buy to offer free next-day delivery feature on various products
Best Buy to offer free next-day delivery feature on various products
By Paroma Bhattacharya

Online retailers are always launching new and attractive deals during the holiday season, as it grosses the highest sale time for the year. Several retailer rollout out attractive offers, such as discounts or complimen...

Nature Tech Corp partners with Aldevron for gene therapy manufacturing
Nature Tech Corp partners with Aldevron for gene therapy manufacturing
By Paroma Bhattacharya

The global cell and gene therapy sector is expected to witness a thriving period of growth over the forthcoming years. In fact, owing to the favorable growth conditions across the industry, numerous biotechnology and p...